Leerink Partnrs Analysts Increase Earnings Estimates for McKesson Co. (NYSE:MCK)

McKesson Co. (NYSE:MCK) – Leerink Partnrs lifted their Q3 2025 EPS estimates for McKesson in a research report issued on Monday, April 22nd. Leerink Partnrs analyst M. Cherny now anticipates that the company will earn $8.23 per share for the quarter, up from their previous forecast of $8.14. Leerink Partnrs currently has a “Outperform” rating on the stock. The consensus estimate for McKesson’s current full-year earnings is $27.59 per share. Leerink Partnrs also issued estimates for McKesson’s Q4 2025 earnings at $8.69 EPS.

Several other research analysts have also recently issued reports on the company. StockNews.com cut McKesson from a “strong-buy” rating to a “buy” rating in a research note on Thursday, January 4th. SVB Leerink assumed coverage on shares of McKesson in a research note on Monday, February 26th. They set an “outperform” rating and a $600.00 price objective for the company. Citigroup increased their price objective on shares of McKesson from $530.00 to $575.00 and gave the stock a “buy” rating in a research note on Thursday, February 8th. Argus raised their target price on shares of McKesson from $510.00 to $570.00 and gave the stock a “buy” rating in a report on Wednesday, April 10th. Finally, Morgan Stanley upped their price target on shares of McKesson from $522.00 to $548.00 and gave the company an “overweight” rating in a report on Monday, April 15th. Two research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $533.50.

McKesson Price Performance

Shares of MCK stock opened at $531.87 on Wednesday. The business has a fifty day moving average of $526.12 and a 200 day moving average of $488.15. The firm has a market capitalization of $69.89 billion, a price-to-earnings ratio of 24.10, a price-to-earnings-growth ratio of 1.43 and a beta of 0.45. McKesson has a 1 year low of $352.34 and a 1 year high of $543.00.

McKesson (NYSE:MCK) last posted its quarterly earnings results on Wednesday, February 7th. The company reported $7.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.05 by $0.69. The business had revenue of $80.90 billion during the quarter, compared to analysts’ expectations of $77.93 billion. McKesson had a net margin of 0.99% and a negative return on equity of 262.63%. The business’s quarterly revenue was up 14.8% on a year-over-year basis. During the same quarter last year, the company posted $6.90 earnings per share.

McKesson Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, April 1st. Investors of record on Friday, March 1st were issued a $0.62 dividend. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $2.48 dividend on an annualized basis and a yield of 0.47%. McKesson’s payout ratio is 11.24%.

Insiders Place Their Bets

In other news, EVP Leann B. Smith sold 186 shares of the company’s stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total transaction of $92,256.00. Following the completion of the transaction, the executive vice president now directly owns 1,511 shares of the company’s stock, valued at approximately $749,456. The sale was disclosed in a filing with the SEC, which is available at this link. In related news, CEO Brian S. Tyler sold 3,473 shares of McKesson stock in a transaction dated Friday, March 15th. The stock was sold at an average price of $524.55, for a total value of $1,821,762.15. Following the sale, the chief executive officer now directly owns 43,445 shares in the company, valued at approximately $22,789,074.75. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Leann B. Smith sold 186 shares of the business’s stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total value of $92,256.00. Following the sale, the executive vice president now owns 1,511 shares of the company’s stock, valued at $749,456. The disclosure for this sale can be found here. 0.21% of the stock is currently owned by company insiders.

Institutional Trading of McKesson

Institutional investors have recently made changes to their positions in the company. Raymond James & Associates grew its holdings in shares of McKesson by 6.1% during the fourth quarter. Raymond James & Associates now owns 153,180 shares of the company’s stock worth $70,919,000 after buying an additional 8,784 shares in the last quarter. Allspring Global Investments Holdings LLC grew its stake in McKesson by 6.8% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 85,779 shares of the company’s stock valued at $39,714,000 after acquiring an additional 5,425 shares in the last quarter. Insight Wealth Strategies LLC acquired a new stake in McKesson in the 4th quarter valued at about $1,813,000. Aspire Private Capital LLC lifted its stake in McKesson by 3.2% in the 3rd quarter. Aspire Private Capital LLC now owns 1,957 shares of the company’s stock worth $851,000 after purchasing an additional 60 shares in the last quarter. Finally, Argus Investors Counsel Inc. acquired a new position in shares of McKesson during the 4th quarter worth approximately $891,000. 85.07% of the stock is owned by institutional investors and hedge funds.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.